Rycarfa 50 mg Tablets for Dogs

国家: 英国

语言: 英文

来源: VMD (Veterinary Medicines Directorate)

现在购买

产品特点 产品特点 (SPC)
27-02-2024

有效成分:

Carprofen

可用日期:

Krka d.d., Novo Mesto

ATC代码:

QM01AE91

INN(国际名称):

Carprofen

药物剂型:

Tablet

处方类型:

POM-V - Prescription Only Medicine – Veterinarian

治疗组:

Dogs

治疗领域:

Anti Inflammatory NSAID

授权状态:

Authorized

授权日期:

2014-04-03

产品特点

                                Revised: February 2019
AN: 00114/2018
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rycarfa 50 mg tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Carprofen
50.00 mg
EXCIPIENTS:
Ferric oxide red (E172)
1.52 mg
Ferric oxide black (E172)
0.95 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Round, dark brown, marbled tablets with visible darker spots, one-side
scored and
bevel-edged.
The tablet can be divided into equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of inflammation and pain caused by musculoskeletal disorders
and
degenerative joint disease. As a follow up to parenteral analgesia in
the management
of post-operative pain.
4.3
CONTRAINDICATIONS
Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in dogs less than 4 months of age.
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in dogs suffering from cardiac, hepatic or renal disease,
where there is a
possibility of gastrointestinal ulceration or bleeding, or where there
is evidence of a
blood dyscrasia.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Revised: February 2019
AN: 00114/2018
Page 2 of 5
Refer to Sections 4.3 and 4.5.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Use in aged dogs may involve additional risk.
If such a use cannot be avoided, dogs may require careful clinical
management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there
is a
potential risk of increased renal toxicity.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment
of
inflammatory conditions associated with bacterial infection,
appropriate concurrent
antimicrobial therapy should be instigated.
See section 4.8.
The tablets are flavoured. In order to avoid any accidental ingestion,
store tablets out
of reach of the animals.
Special
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报